Applying evidence-based methods to the development and use of adverse outcome pathways

evidence-based non-animal method systematic review adverse outcome pathway risk assessment

Journal

ALTEX
ISSN: 1868-8551
Titre abrégé: ALTEX
Pays: Germany
ID NLM: 100953980

Informations de publication

Date de publication:
2021
Historique:
received: 21 01 2021
accepted: 25 01 2021
entrez: 10 4 2021
pubmed: 11 4 2021
medline: 29 10 2021
Statut: ppublish

Résumé

The workshop “Application of evidence-based methods to construct mechanistic frameworks for the development and use of non-animal toxicity tests” was organized by the Evidence-based Toxicology Collaboration and hosted by the Grading of Recommendations Assessment, Development and Evaluation Working Group on June 12, 2019. The purpose of the workshop was to bring together international regulatory bodies, risk assessors, academic scientists, and industry to explore how systematic review methods and the adverse outcome pathway framework could be combined to develop and use mechanistic test methods for predicting the toxicity of chemical substances in an evidence-based manner. The meeting covered the history of biological frameworks, the way adverse outcome pathways are currently developed, the basic principles of systematic methodology, including systematic reviews and evidence maps, and assessment of cer­tainty in models, and adverse outcome pathways in particular. Specific topics were discussed via case studies in small break-out groups. The group concluded that adverse outcome pathways provide an important framework to support mechanism-based assessment in environmental health. The process of their development has a few challenges that could be addressed with systematic methods and automation tools. Addressing these challenges will increase the transparency of the evidence behind adverse outcome pathways and the consistency with which they are defined; this in turn will increase their value for supporting public health decisions. It was suggested to explore the details of applying systematic methods to adverse outcome pathway development in a series of case studies and workshops.

Identifiants

pubmed: 33837437
doi: 10.14573/altex.2101211
pmc: PMC9394185
mid: NIHMS1734900
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

336-347

Subventions

Organisme : Intramural NIH HHS
ID : Z99 ES999999
Pays : United States

Références

Environ Int. 2018 Dec;121(Pt 1):1027-1031
pubmed: 30166065
Chemosphere. 2015 Feb;120:764-77
pubmed: 25439131
Environ Int. 2016 Jul-Aug;92-93:617-29
pubmed: 26857180
J Epidemiol Community Health. 2011 May;65(5):392-5
pubmed: 20947872
Environ Health Perspect. 2016 May;124(5):556-62
pubmed: 26431337
Environ Health Perspect. 2014 Oct;122(10):1040-51
pubmed: 24968389
Environ Health Perspect. 2014 Oct;122(10):1007-14
pubmed: 24968373
Environ Sci Technol. 2015 Jul 21;49(14):8804-14
pubmed: 26066997
Environ Int. 2016 Jul-Aug;92-93:556-64
pubmed: 26687863
Arch Toxicol. 2017 Nov;91(11):3477-3505
pubmed: 29051992
Pharmacol Ther. 2016 Sep;165:79-92
pubmed: 27218886
Regul Toxicol Pharmacol. 2016 Mar;75:46-57
pubmed: 26724267
Crit Rev Toxicol. 2018 May;48(5):344-358
pubmed: 29474128
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
Environ Int. 2019 Sep;130:104871
pubmed: 31254867
Environ Health. 2016 Jul 14;15(1):74
pubmed: 27412149
J Chronic Dis. 1984;37(5):343-52
pubmed: 6371037
Toxicol Sci. 2015 Nov;148(1):137-54
pubmed: 26272952
J Clin Epidemiol. 2021 Jan;129:138-150
pubmed: 32980429
BMJ. 2013 Jan 10;346:f139
pubmed: 23305843
Proc R Soc Med. 1965 May;58:295-300
pubmed: 14283879
J Appl Toxicol. 2014 Nov;34(11):1115-21
pubmed: 25244189
Control Clin Trials. 1996 Feb;17(1):1-12
pubmed: 8721797
Int J Technol Assess Health Care. 2017 Jan;33(2):176-182
pubmed: 28655365
Environ Health Perspect. 2014 Jul;122(7):A176-7
pubmed: 24984224
J Chronic Dis. 1985;38(4):339-51
pubmed: 3923014
Environ Health Perspect. 2014 Jul;122(7):711-8
pubmed: 24755067
Environ Int. 2016 Jul-Aug;92-93:611-6
pubmed: 26827182
J Appl Toxicol. 2018 Dec;38(12):1460-1470
pubmed: 29806706
Environ Health Perspect. 2016 Jun;124(6):713-21
pubmed: 26600562
ALTEX. 2019 May 16;36(3):508-517
pubmed: 31113000
ALTEX. 2017 Oct 2;35(2):179-192
pubmed: 28968481
Arch Toxicol. 2017 Jul;91(7):2551-2575
pubmed: 28501917
Toxicol Sci. 2016 Jul;152(1):10-6
pubmed: 27208075
Toxicol Sci. 2014 Dec;142(2):321-30
pubmed: 25466379
Eur J Clin Nutr. 2005 Aug;59 Suppl 1:S147-9; discussion S195-6
pubmed: 16052183
Syst Rev. 2016 May 23;5:87
pubmed: 27216467
BMC Med Res Methodol. 2014 Mar 26;14:43
pubmed: 24667063
Crit Rev Toxicol. 2018 May;48(5):359-374
pubmed: 29474122

Auteurs

Rob B M De Vries (RBM)

Evidence-Based Toxicology Collaboration (EBTC) at Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Michelle Angrish (M)

United States Environmental Protection Agency, Office of Research and Development, Center for Public Health and Environmental Assessments, Research Triangle Park, NC, USA.

Patience Browne (P)

Test Guidelines Programme, Environmental Directorate, OECD, Paris, France.

Jan Brozek (J)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.

Andrew A Rooney (AA)

Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.

Daniele S Wikoff (DS)

ToxStrategies, Asheville, NC, USA.

Paul Whaley (P)

Evidence-Based Toxicology Collaboration (EBTC) at Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Lancaster Environment Centre, Lancaster University, Lancaster, UK.

Stephen W Edwards (SW)

RTI International, Research Triangle Park, NC, USA.

Rebecca L Morgan (RL)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.

Ingrid L Druwe (IL)

United States Environmental Protection Agency, Office of Research and Development, Center for Public Health and Environmental Assessments, Research Triangle Park, NC, USA.

Sebastian Hoffmann (S)

Evidence-Based Toxicology Collaboration (EBTC) at Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
seh consulting + service, Paderborn, Germany.

Thomas Hartung (T)

Center for Alternatives to Animal Testing (CAAT) at Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Kristina Thayer (K)

United States Environmental Protection Agency, Office of Research and Development, Center for Public Health and Environmental Assessments, Research Triangle Park, NC, USA.

Marc T Avey (MT)

ICF, Durham, NC, USA.

Brandiese E J Beverly (BEJ)

Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.

Maicon Falavigna (M)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
National Institute for Health Technology Assessment, UFRGS, Porto Alegre, Brazil.

Catherine Gibbons (C)

United States Environmental Protection Agency, Office of Research and Development, Center for Public Health and Environmental Assessments, Research Triangle Park, NC, USA.

Katy Goyak (K)

ExxonMobil Biomedical Sciences Inc., Annandale, NJ, USA.

Andrew Kraft (A)

United States Environmental Protection Agency, Office of Research and Development, Center for Public Health and Environmental Assessments, Research Triangle Park, NC, USA.

Fernando Nampo (F)

Evidence-Based Public Health Research Group, Latin-American Institute of Life and Nature Sciences, Federal University of Latin-American Integration, Foz do Iguassu, Parana, Brazil.

Amir Qaseem (A)

Center for Evidence Reviews, The American College of Physicians, Philadelphia, PA, USA.

Meg Sears (M)

Canadian Environmental Health Information Infrastructure, Ottawa Hospital Research Institute, Ottawa, ON, Canada.

Jasvinder A Singh (JA)

Medicine Service, VA Medical Center, Birmingham, AL, USA; Department of Medicine at the School of Medicine, University of Alabama at Birmingham (UAB), Birmingham, AL, USA; and Department of Epidemiology at the UAB School of Public Health, Birmingham, AL, USA.

Catherine Willett (C)

Humane Society International, Washington, DC, USA.

Erin Y Yost (EY)

United States Environmental Protection Agency, Office of Research and Development, Center for Public Health and Environmental Assessments, Research Triangle Park, NC, USA.

Holger Schünemann (H)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
McMaster GRADE Centre and Michael G DeGroote Cochrane Canada Centre, McMaster University, Hamilton, ON, Canada.

Katya Tsaioun (K)

Evidence-Based Toxicology Collaboration (EBTC) at Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Articles similaires

Humans Self-Control Longitudinal Studies Child, Preschool Child

Why experimental variation in neuroimaging should be embraced.

Gregory Kiar, Jeanette A Mumford, Ting Xu et al.
1.00
Humans Neuroimaging Brain Reproducibility of Results Magnetic Resonance Imaging

Classifications MeSH